North America continues to play a significant role in the growth of the In Situ Hybridization (ISH) market, supported by advanced healthcare infrastructure, strong research capabilities, and increasing adoption of molecular diagnostic technologies. The region remains a key hub for biotechnology and life sciences innovation, encouraging the use of sophisticated diagnostic tools for disease...